Erythropoietic-stimulating agents: the cancer progression controversy and collateral damage to the blood supply.
John W
JW
Adamson
D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D006397:Hematinics / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000401:mortality; D018570:Risk Assessment
D006397:Hematinics